Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 314
Magel, V, Blum, J, Dolde, X, Leisner, H, Grillberger, K, Khalidi, H, Gardner, I, Ecker, GF, Pallocca, G, Dreser, N & Leist, M 2024, 'Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants', Cells, vol. 13, no. 24, 2057. https://doi.org/10.3390/cells13242057

Li, E, Boujeddaine, N, Houtman, MJC, Maas, RGC, Sluijter, JPG, Ecker, GF, Stary-Weinzinger, A, van Ham, WB & van der Heyden, MAG 2024, 'Development of new Kir2.1 channel openers from propafenone analogues', British Journal of Pharmacology, vol. 182, no. 3, pp. 633-650. https://doi.org/10.1111/bph.17377

Ortega-Vallbona, R, Palomino-Schätzlein, M, Tolosa, L, Benfenati, E, Ecker, GF, Gozalbes, R & Serrano-Candelas, E 2024, 'Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study', International Journal of Molecular Sciences, vol. 25, no. 20, 11154. https://doi.org/10.3390/ijms252011154

Digles, D, Ingles-Prieto, A, Dvorak, V, Mocking, TAM, Goldmann, U, Garofoli, A, Homan, EJ, Di Silvio, A, Azzollini, L, Sassone, F, Fogazza, M, Bärenz, F, Pommereau, A, Zuschlag, Y, Ooms, JF, Tranberg-Jensen, J, Hansen, JS, Stanka, J, Sijben, HJ, Batoulis, H, Bender, E, Martini, R, IJzerman, AP, Sauer, DB, Heitman, LH, Manolova, V, Reinhardt, J, Ehrmann, A, Leippe, P, Ecker, GF, Huber, KVM, Licher, T, Scarabottolo, L, Wiedmer, T & Superti-Furga, G 2024, 'Advancing drug discovery through assay development: a survey of tool compounds within the human solute carrier superfamily', Frontiers in Pharmacology, vol. 15, 1401599. https://doi.org/10.3389/fphar.2024.1401599

Activities

Leveraging linked open data - from transporter profiling to toxicity prediction and beyond

Gerhard Ecker
Talk or oral contribution
21.3.2017 - 21.3.2017

Leveraging linked open data - from transporter interaction profiling to toxicity prediction and beyond

Gerhard Ecker
Janssen internal computational chemistry meeting
Lecture series, colloquium, Talk or oral contribution
15.3.2017 - 15.3.2017

Exploiting semantically integrated life science data - from transporter profiling to toxicity prediction

Gerhard Ecker
1st MuTaLig COST Action Training School
Summer/Winter school, Talk or oral contribution
9.2.2017 - 9.2.2017

The power of open data - linking transporter interaction profiles to in vivo toxicity

Gerhard Ecker
Talk or oral contribution
3.2.2017 - 3.2.2017

Leveraging linked open data - from transporter interaction profiles to toxicity prediction

Gerhard Ecker
Talk or oral contribution
19.1.2017 - 19.1.2017